← Leaderboards
Naftali Kaminski
Yale University
$42,947,928
Attributed
$74,951,591
Total exposure
20
Grants
13
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $10.1M · FY2005–25$20M$15M$10M$5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$74,951,591 · 20
By mechanism
R01$17,634,176 · 5
U01$17,234,144 · 4
RC2$14,890,943 · 2
UH3$9,549,597 · 2
T32$7,384,700 · 1
P50$3,038,548 · 1
Top collaborators
- Panagiotis V Benos17 shared
- Namasivayam Ambalavanan5 shared
- Gregory Paul Downey5 shared
- James S Hagood5 shared
- Steven D Shapiro5 shared
- Ferhaan Ahmad4 shared
- Michael John Becich4 shared
- Stephen R Wisniewski4 shared
Most similar at Yale University
Same institution · by research overlap
- Jon S Morrow$10,953,980
- Amy Yue-Ting Zhao$172,728
- Mary E. Choi$7,200,453
- Frank Wendt$117,681
- Aurora Esquela Kerscher$1,035,873
Others in their field
Top investigators on “Lung”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$372,040,227
- Chanza Baytop · Westat, Inc.$271,217,917
- Richard K. Wilson · Washington University$201,818,043
- Walter John Curran · Thomas Jefferson University$112,093,071
Research focus
LungCellsTissuesPhenotypeFibrosisGene ExpressionGenomicsPathway InteractionsLung DiseasesResponseValidationAffectBaseExtracellular MatrixChronicStructure Of Parenchyma Of LungMolecularGenesDesignComputational BiologyPatternSamplingEpithelial CellsResearch Personnel
Grant awards (88)
Genomic Analysis of Tissue and Cellular Heterogeneity in IPF$698,173
R01 · FY2025 · HL · contact PI
Genomic Analysis of Tissue and Cellular Heterogeneity in IPF$685,000
R01 · FY2024 · HL · contact PI
Training in Translational Lung Biology and Pathobiology$552,994
T32 · FY2024 · HL · contact PI
Genomic Analysis of Tissue and Cellular Heterogeneity in IPF$90,433
R01 · FY2024 · HL · contact PI
Training in Translational Lung Biology and Pathobiology$872,892
T32 · FY2023 · HL · contact PI
Genomic Analysis of Tissue and Cellular Heterogeneity in IPF$707,519
R01 · FY2023 · HL · contact PI
Integrating single-cell based transcriptomic signatures for identifying therapeutic targets of COPD$125,625
R21 · FY2023 · HL · contact PI
Genomic Analysis of Tissue and Cellular Heterogeneity in IPF$90,433
R01 · FY2023 · HL · contact PI
Epithelial Protective Effects of Thyroid Hormone Signaling in Fibrosis$788,105
R01 · FY2022 · HL · contact PI
Genomic Analysis of Tissue and Cellular Heterogeneity in IPF$750,208
R01 · FY2022 · HL · contact PI
Training in Translational Lung Biology and Pathobiology$630,511
T32 · FY2022 · HL · contact PI
Normal Aging Lung Cell Atlas (NALCA)$626,104
U01 · FY2022 · HL · contact PI
Integrating single-cell based transcriptomic signatures for identifying therapeutic targets of COPD$125,625
R21 · FY2022 · HL · contact PI
Normal Aging Lung Cell Atlas (NALCA)$86,005
U01 · FY2022 · HL · contact PI
Use of the Src Family Kinase Inhibitor Saracatinib in the Treatment of Pulmonary Fibrosis$1,511,058
UH3 · FY2021 · TR
Epithelial Protective Effects of Thyroid Hormone Signaling in Fibrosis$879,865
R01 · FY2021 · HL · contact PI
Training in Translational Lung Biology and Pathobiology$805,700
T32 · FY2021 · HL · contact PI
Normal Aging Lung Cell Atlas (NALCA)$641,786
U01 · FY2021 · HL · contact PI
Normal Aging Lung Cell Atlas (NALCA)$86,005
U01 · FY2021 · HL · contact PI
Use of the Src Family Kinase Inhibitor Saracatinib in the Treatment of Pulmonary Fibrosis$1,726,316
UH3 · FY2020 · TR
Epithelial Protective Effects of Thyroid Hormone Signaling in Fibrosis$826,057
R01 · FY2020 · HL · contact PI
Training in Translational Lung Biology and Pathobiology$800,827
T32 · FY2020 · HL · contact PI
Normal Aging Lung Cell Atlas (NALCA)$662,572
U01 · FY2020 · HL · contact PI
Epithelial Protective Effects of Thyroid Hormone Signaling in Fibrosis$69,985
R01 · FY2020 · HL · contact PI
Use of the Src Family Kinase Inhibitor Saracatinib in the Treatment of Pulmonary Fibrosis$1,672,515
UH3 · FY2019 · TR
Epithelial Protective Effects of Thyroid Hormone Signaling in Fibrosis$803,109
R01 · FY2019 · HL · contact PI
Normal Aging Lung Cell Atlas (NALCA)$731,345
U01 · FY2019 · HL · contact PI
Training in Translational Lung Biology and Pathobiology$318,152
T32 · FY2019 · HL · contact PI
Use of the Src Family Kinase Inhibitor Saracatinib in the Treatment of Pulmonary Fibrosis$97,416
UH3 · FY2019 · TR
Mir-29 mimicry as a therapy for pulmonary fibrosis$1,387,947
UH3 · FY2018 · HL · contact PI
Use of the Src Family Kinase Inhibitor Saracatinib in the Treatment of Pulmonary Fibrosis$853,963
UG3 · FY2018 · TR
Alveolar DevMAP$734,685
U01 · FY2018 · HL
Genomic Analysis of Tissue and Cellular Heterogeneity in IPF$685,322
R01 · FY2018 · HL · contact PI
Training in Translational Lung Biology and Pathobiology$676,294
T32 · FY2018 · HL · contact PI
Mir-29 mimicry as a therapy for pulmonary fibrosis$1,719,886
UH3 · FY2017 · HL · contact PI
Alveolar DevMAP$742,417
U01 · FY2017 · HL
Genomic Analysis of Tissue and Cellular Heterogeneity in IPF$702,354
R01 · FY2017 · HL · contact PI
Training in Translational Lung Biology and Pathobiology$555,990
T32 · FY2017 · HL · contact PI
Training in Translational Lung Biology and Pathobiology$1,318
T32 · FY2017 · HL · contact PI
Mir-29 mimicry as a therapy for pulmonary fibrosis$1,434,459
UH3 · FY2016 · HL · contact PI
Alveolar DevMAP$734,777
U01 · FY2016 · HL
Genomic Analysis of Tissue and Cellular Heterogeneity in IPF$713,806
R01 · FY2016 · HL · contact PI
Training in Translational Lung Biology and Pathobiology$657,856
T32 · FY2016 · HL · contact PI
Sarcoidosis and A1AT Genomics & Informatics Center$2,447,769
U01 · FY2015 · HL
Mir-29 mimicry as a therapy for pulmonary fibrosis$1,278,604
UH2 · FY2015 · HL · contact PI
Genomic Analysis of Tissue and Cellular Heterogeneity in IPF$818,314
R01 · FY2015 · HL · contact PI
Alveolar DevMAP$734,976
U01 · FY2015 · HL
Training in Translational Lung Biology and Pathobiology$639,677
T32 · FY2015 · HL · contact PI
Mir-29 mimicry as a therapy for pulmonary fibrosis$1,431,654
UH2 · FY2014 · HL · contact PI
Alveolar DevMAP$740,050
U01 · FY2014 · HL
Gene networks beyond organ boundaries; heart, lung and pulmonary vascular disease$497,772
U01 · FY2014 · HL · contact PI
Sarcoidosis and A1AT Genomics & Informatics Center$390,000
U01 · FY2014 · HL
Training in Respiratory Biology and Pathobiology$267,177
T32 · FY2014 · HL · contact PI
Sarcoidosis and A1AT Genomics & Informatics Center$3,628,231
U01 · FY2013 · HL
Training in Respiratory Biology and Pathobiology$605,312
T32 · FY2013 · HL · contact PI
Gene networks beyond organ boundaries; heart, lung and pulmonary vascular disease$517,785
U01 · FY2013 · HL · contact PI
Sarcoidosis and A1AT Genomics & Informatics Center$2,068,387
U01 · FY2012 · HL · contact PI
Gene networks beyond organ boundaries; heart, lung and pulmonary vascular disease$581,739
U01 · FY2012 · HL · contact PI
Molecular Phenotypes within and across disease boundaries in IPF and COPD$711,424
R01 · FY2011 · HL · contact PI
Gene networks beyond organ boundaries; heart, lung and pulmonary vascular disease$581,739
U01 · FY2011 · HL · contact PI
Modeling in vivo Protein-DNA Interactions from High-Throughput Data MP1/1$465,349
R01 · FY2011 · LM
Lung Genomics Research Consortium$3,759,656
RC2 · FY2010 · HL
Linking Genetics, Genomics and Phenomics to Better Understand Asthma Severity$1,787,959
RC2 · FY2010 · HL
Lung Genomics Research Consortium$1,654,805
RC2 · FY2010 · HL
Molecular Phenotypes within and across disease boundaries in IPF and COPD$718,962
R01 · FY2010 · HL · contact PI
Surrogate Biomarkers for Disease Progression in IPF$516,024
P50 · FY2010 · HL · contact PI
Genome-Wide Association and Exon Sequencing Study in IPF$500,000
RC1 · FY2010 · HL
Modeling in vivo Protein-DNA Interactions from High-Throughput Data MP1/1$470,983
R01 · FY2010 · LM
Lung Genomics Research Consortium$5,987,215
RC2 · FY2009 · HL
Linking Genetics, Genomics and Phenomics to Better Understand Asthma Severity$1,701,308
RC2 · FY2009 · HL
Molecular Phenotypes within and across disease boundaries in IPF and COPD$738,001
R01 · FY2009 · HL · contact PI
Surrogate Biomarkers for Disease Progression in IPF$501,914
P50 · FY2009 · HL · contact PI
Genome-Wide Association and Exon Sequencing Study in IPF$500,000
RC1 · FY2009 · HL
Modeling in vivo Protein-DNA Interactions from High-Throughput Data MP1/1$462,252
R01 · FY2009 · LM
Modeling in vivo Protein-DNA Interactions from High-Throughput Data MP1/1$224,578
R01 · FY2009 · LM
Molecular Phenotypes within and across disease boundaries in IPF and COPD$18,265
R01 · FY2009 · HL · contact PI
Surrogate Biomarkers for Disease Progression in IPF$771,211
P50 · FY2008 · HL · contact PI
Molecular Phenotypes within and across disease boundaries in IPF and COPD$770,981
R01 · FY2008 · HL · contact PI
Modeling in vivo Protein-DNA Interactions from High-Throughput Data MP1/1$449,157
R01 · FY2008 · LM
Surrogate Biomarkers for Disease Progression in IPF$693,698
P50 · FY2007 · HL · contact PI
Modeling in vivo Protein-DNA Interactions from High-Throughput Data MP1/1$450,324
R01 · FY2007 · LM
New Molecular Targets in Pulmonary Fibrosis$698,530
R01 · FY2006 · HL · contact PI
Surrogate Biomarkers for Disease Progression in IPF$555,701
P50 · FY2006 · HL · contact PI
Proteomics of Idiopathic Pulmonary Fibrosis$181,262
R21 · FY2006 · HL · contact PI
New Molecular Targets in Pulmonary Fibrosis$715,825
R01 · FY2005 · HL
Proteomics of Idiopathic Pulmonary Fibrosis$222,750
R21 · FY2005 · HL
New Molecular Targets in Pulmonary Fibrosis$717,280
R01 · FY2004 · HL
New Molecular Targets in Pulmonary Fibrosis$713,582
R01 · FY2003 · HL